1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Drug Focus OCTOBER 2016

Autoimmune Drug Focus OCTOBER 2016

  • October 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Arthritis Set To Lead Field In New Autoimmune Drugs
Industry Brief - Neovacs Signs Deal To Achieve PoC For IFNalpha-Kinoid In Type I Diabetes
Industry Brief - Sotagliflozin Phase II Dose-Ranging Study Meets Primary Endpoint
Industry Brief - Filgotinib To Progress To Phase III Studies
Industry Trend Analysis - MEDI2070 Promises Potential Rewards In An Increasingly Competitive Marketplace
Industry Brief - Tillotts Secures Japanese Zentacort Approval
Industry Brief - TiGenix' Cx601 Granted Crohn's Disease ODD
Industry Brief - First Patients Dosed In TOP1288 Phase IIa PoC Study For UC
Industry Brief - Cellceutix Reports Interim Results From Brilacidin Phase II UP\UPS Trial
Industry Brief - Apitope Regains Global Rights To Novel MS Treatment
Industry Brief - RedHill Receives Japanese Patent NoA Supporting RHB-104 For MS
Industry Brief - Actemra Granted FDA Breakthrough Therapy Designation In GCA
Industry Trend Analysis - Celltrion Agreement Will Reinvigorate Teva's Biosimilar Efforts
Industry Brief - Cimzia AutoClicks Prefilled Pen Now Available On NHS
Industry Trend Analysis - Adalimumab Taking Shape As Next Major Biosimilar Competition Market
Industry Brief - Lumicef Launch In Japan For Psoriasis
Industry Brief - Cimzia Phase III Trial Meets Co-Primary Efficacy Endpoint
Industry Brief - Guselkumab Shows Superiority Over Humira In Phase III Plaque Psoriasis Study
Industry Brief - Late-Breaking Data Revealed For Cosentyx In Psoriasis At Four Years
Industry Brief - Biocad's BCD-085 Phase II Trial Initiated In Severe Psoriasis
Industry Brief - Otezla Gains NICE Chronic Plaque Psoriasis Recommendation
Industry Brief - Voclosporin Achieves Pre-Specified Secondary Endpoints In Phase IIb LN Study
Industry Brief - Evotec Enters Into Collaboration With C4X Discovery
Industry Brief - First Patient Treated With IdeS In Phase II Acquired TTP study
Industry Brief - TNT009 Gains ODD for Treatment Of Autoimmune Haemolytic Anaemia
Industry Brief - Selexis/ImmuNext Enter Deal For Anti-CD40L Antibody To Treat Chronic Autoimmune Disorders
Industry Trend Analysis - Shire Turns Away From Biosimilars
Industry Brief - Allergan's Acquisition Of Vitae Progresses
Industry Brief - True North Therapeutics Completes Fundraising
Industry Trend Analysis - South Africa Will Be The First Stage In Cipla's Wider Biosimilar Ambitions
Industry Brief - Autoimmune Conferences - January 2017

Table Of Contents

Autoimmune Drug Focus OCTOBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.